|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00660 WAI CHUN BIOTEC
Nominal 
0.208 +0.013 (+6.667%) | 2025/06 - Final HKD(K$) | %Chg (Compare to Final) | 2024/06 HKD(K$) | 2023/06 HKD(K$) | 2022/06 HKD(K$) | 2020/12 HKD(K$) | |
| Turnover | 377,168 | 1.918% | 370,069 | 773,654 | 1,007,186 | 567,553 |
| Cost of Sales | (341,164) | 1.571% | (335,888) | (723,241) | (917,001) | (518,623) |
| Gross Profit | 36,004 | 5.333% | 34,181 | 50,413 | 90,185 | 48,930 |
| 2025/06 - Final HKD(K$) | %Chg (Compare to Final) | 2024/06 HKD(K$) | 2023/06 HKD(K$) | 2022/06 HKD(K$) | 2020/12 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | (1,748) | -96.994% | (58,149) | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | (8,931) | -88.574% | (78,167) | (5,698) | 3,777 | 1,611 | |
| Taxation | (1,770) | -- | 12,460 | (4,364) | (5,167) | (616) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 3,922 | -81.754% | 21,495 | (5,371) | (20,155) | (9,144) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (14,623) | -66.925% | (44,212) | (15,433) | (21,545) | (8,149) | |
| 2025/06 - Final HKD(K$) | %Chg (Compare to Final) | 2024/06 HKD(K$) | 2023/06 HKD(K$) | 2022/06 HKD(K$) | 2020/12 HKD(K$) | |
| Net Finance Costs / (Income) | 13,647 | -23.747% | 17,897 | 17,076 | 20,924 | 7,889 |
| Depreciation & Amortisation | 13,177 | 16.005% | 11,359 | 14,062 | 16,198 | 6,375 |
| Directors' Emoluments | -- | -- | 2,232 | 1,549 | 4,737 | 2,760 |
| 2025/06 - Final | %Chg (Compare to Final) | 2024/06 | 2023/06 | 2022/06 | 2020/12 | |
| Auditor's Opinion Status | Unqualified (Modified Report) | -- | Unqualified (Modified Report) | Unqualified (Modified Report) | Unqualified (Modified Report) | Unqualified (Modified Report) |
Market Valuation Indicators
| 2025/06 - Final | %Chg (Compare to Final) | 2024/06 | 2023/06 | 2022/06 | 2020/12 | |
| EPS (cts) | -8.430 | -67.300% | -25.780 | -9.100 | -12.900 | -4.900 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | 0.304 | 0.289 | 0.029 | (0.002) |
| NBV per share ($) | (0.510) | -- | (0.462) | (0.204) | (0.224) | (0.226) |
| Remarks: | Real time quote last updated: 28/10/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD -14,623 |
| %Change | -66.925% |
| EPS / (LPS) | HKD -0.084 |
| NBV Per Share ($) | HKD -0.510 |